Cryoballoon Catheter Ablation in Korean Patients With Paroxysmal and Persistent Atrial Fibrillation: One Year Outcome From the Cryo Global Registry

다국어 초록 (Multilingual Abstract)

Background and Objectives: Cryoballoon catheter ablation for the treatment of patients with symptomatic atrial fibrillation (AF) has been adopted globally, but there are limited multicenter reports of 12-month outcomes in the Korean patient population. This analysis evaluated the clinical performance and safety of cryoballoon ablation (CBA) according to standard-of-care practices in Korea.
Methods: This evaluation of Korean patients with AF was conducted within the larger Cryo Global Registry, which is a prospective, multicenter, post-market registry. Freedom from a ≥30-second recurrence of atrial arrhythmias (after a 90-day blanking period until 12 months) and procedural safety were examined in subjects treated with CBA at 3 Korean centers.
Results: Overall, 299 patients with AF (60±11 years old, 24.7% female, 50.5% paroxysmal AF) underwent CBA using the Arctic Front Advance cryoballoon. Of those, 298 were followed-up for at least 12 months. Mean procedure-, left atrial dwell- and fluoroscopy time was 76±21 minutes, 56±23 minutes, and 27±23 minutes, respectively. Freedom from AF recurrence at 12 months was 83.9% (95% confidence interval [CI], 76.9–88.9%) in the paroxysmal and 61.6% (95% CI, 53.1–69.0%) in the persistent AF cohort. Rhythm monitoring was performed on average 4.7±1.4 times during the follow-up period. Serious device- or procedure-related adverse events occurred in 2 patients (0.7%). The 12-month Kaplan-Meier estimate of freedom from repeat ablation and cardiovascular-related hospitalization was 93.8% (95% CI, 90.4–96.1%) and 89.7% (95% CI, 85.6–92.7%), respectively.
Conclusions: CBA is an efficient, effective, and safe procedure for the treatment of AF patients when used according to real-world practices in Korea.

참고문헌 (Reference)

1 Cappato R, "Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation" 111 : 1100-1105, 2005

2 Cappato R, "Surveys and registries on catheter ablation of atrial fibrillation : fifteen years of history" 14 : e008073-, 2021

3 Chun KR, "Safety and efficacy of cryoballoon ablation for the treatment of paroxysmal and persistent AF in a real-world global setting : results from the Cryo AF Global Registry" 37 : 356-367, 2021

4 Providencia R, "Results from a multicentre comparison of cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation : is cryoablation more reproducible?" 19 : 48-57, 2017

5 Kwon HJ, "Radiofrequency vs. cryoballoon vs. thoracoscopic surgical ablation for atrial fibrillation: a single-center experience" 57 : 1023-, 2021

6 Padeletti L, "Pulmonary vein isolation with the cryoballoon technique : feasibility, procedural outcomes, and adoption in the real world : data from One Shot Technologies TO Pulmonary Vein Isolation(1STOP)project" 40 : 46-56, 2017

7 Friedman DJ, "Procedure characteristics and outcomes of atrial fibrillation ablation procedures using cryoballoon versus radiofrequency ablation : a report from the GWTG-AFIB registry" 32 : 248-259, 2021

8 Ferrero-De-Loma-Osorio Á, "Primary results of the Spanish Cryoballoon Ablation Registry : acute and long-term outcomes of the RECABA study" 11 : 17268-, 2021

9 Hoffmann E, "Outcomes of cryoballoon or radiofrequency ablation in symptomatic paroxysmal or persistent atrial fibrillation" 21 : 1313-1324, 2019

10 Velagić V, "Learning curve using the second-generation cryoballoon ablation" 18 : 518-527, 2017

11 Balabanski T, "Impact of monitoring on detection of arrhythmia recurrences in the ESC-EHRA EORP atrial fibrillation ablation long-term registry" 21 : 1802-1808, 2019

12 Pak HN, "Cryoballoon versus high-power, short-duration radiofrequency ablation for pulmonary vein isolation in patients with paroxysmal atrial fibrillation : a single-center, prospective, randomized study" 14 : e010040-, 2021

13 Hindricks G, "2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery(EACTS) : the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology(ESC)Developed with the special contribution of the European Heart Rhythm Association(EHRA)of the ESC" 42 : 373-498, 2021

14 Calkins H, "2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation" 20 : e1-160, 2018

15 Calkins H, "2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation : recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design" 14 : 528-606, 2012